RXEI logo

RxElite, Inc. Stock Price

OTCPK:RXEI Community·US$116.0 Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

RXEI Share Price Performance

US$0.000001
0.00 (0.00%)
US$0.000001
0.00 (0.00%)
Price US$0.000001

RXEI Community Narratives

There are no narratives available yet.

Snowflake Analysis

Low with weak fundamentals.

3 Risks
0 Rewards

RxElite, Inc. Key Details

US$10.4m

Revenue

US$9.2m

Cost of Revenue

US$1.2m

Gross Profit

US$30.4m

Other Expenses

-US$29.2m

Earnings

Last Reported Earnings
Sep 30, 2008
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About RXEI

Founded
n/a
Employees
n/a
CEO
n/a
WebsiteView website
www.piramalcriticalcare.com

RxElite, Inc. engages in the development, manufacture, and marketing of generic prescription drug products in specialty generic markets. Its products include Sterile Liquid Dose products that consist of generic ophthalmic products in unit and multi-dose presentations, sterile unit dose inhalation respiratory products, and injectable drugs. The company, through its subsidiaries, also manufactures active pharmaceutical ingredients for pharmaceutical companies in the United States, Europe, and Asia. Its customers include hospitals and hospital group purchasing organizations, national and regional wholesalers, direct retail pharmacy stocking chains, homecare companies, and outpatient surgery centers and ambulatory care clinics. The company has partnership agreements with Stason Pharmaceuticals, Inc.; Alkem Laboratories Limited; and Zach Systems S.p.A. RxElite is headquartered in Meridian, Idaho. RxElite Inc. operates as a subsidiary of Piramal Healthcare Ltd.

Recent RXEI News & Updates

No updates

Recent updates

No updates